How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience
暂无分享,去创建一个
M. Kalyoncu | H. E. Sönmez | M. Çakan | Ş. Karadağ | S. Bakkaloğlu | N. Ayaz | B. Makay | S. Ozdel | B. Sözeri | M. Bülbül | Ş. Çağlayan | Esra Bağlan | Kübra Öztürk | F. Demir | G. O. Yener | Ş. E. Ünsal | Deniz Gezgin Yıldırım | Tuncay Aydın | Özlem Akgün | Semanur Ozdel | İlknur Bağrul | Özge Baba
[1] M. Çakan,et al. Time to collaborate: Objectives, design, and methodology of PeRA-Research Group , 2021, Northern clinics of Istanbul.
[2] F. Bagnasco,et al. Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era , 2019, Arthritis Research & Therapy.
[3] R. Schneider,et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non‐Systemic Polyarthritis, Sacroiliitis, and Enthesitis , 2019, Arthritis care & research.
[4] N. Wulffraat,et al. Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus , 2018, The Journal of Rheumatology.
[5] T. Herlin,et al. Clinical Outcome and Long-term Remission in JIA , 2017, Current Rheumatology Reports.
[6] N. Menon,et al. Clinical profile and juvenile arthritis damage index in children with juvenile idiopathic arthritis: A study from a tertiary care center in south India , 2016, International journal of rheumatic diseases.
[7] E. Haddad,et al. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort , 2014, Annals of the rheumatic diseases.
[8] R. Cron,et al. Treatment of juvenile idiopathic arthritis in the biologic age. , 2013, Rheumatic diseases clinics of North America.
[9] Bin Huang,et al. Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. , 2012, Arthritis and rheumatism.
[10] M. Beresford,et al. Juvenile Idiopathic Arthritis , 2011, Paediatric drugs.
[11] K. Aalto,et al. Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis (ACUTE–JIA): a multicentre randomised open-label clinical trial , 2011, Annals of the rheumatic diseases.
[12] Alberto Martini,et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features , 2011, Arthritis care & research.
[13] A. Martini,et al. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial , 2008, The Lancet.
[14] J. Norris,et al. Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis , 2007, Annals of the rheumatic diseases.
[15] C. Wouters,et al. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. , 2007, Arthritis and rheumatism.
[16] R. Saurenmann,et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. , 2007, Arthritis and rheumatism.
[17] Bin Huang,et al. Patterns of clinical remission in select categories of juvenile idiopathic arthritis. , 2005, Arthritis and rheumatism.
[18] A. Martini,et al. Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis. , 2005, Arthritis and rheumatism.
[19] A Ravelli,et al. Toward an understanding of the long-term outcome of juvenile idiopathic arthritis. , 2004, Clinical and experimental rheumatology.
[20] M. Suarez‐Almazor,et al. International League of Associations for Rheumatology: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001 , 2004 .
[21] B. Dijkmans,et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. , 2004, Arthritis and rheumatism.
[22] M. Cheang,et al. Radiologic outcome and its relationship to functional disability in juvenile rheumatoid arthritis. , 2003, The Journal of rheumatology.
[23] A. Zwinderman,et al. Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis. , 2003, The Journal of rheumatology.
[24] Andre Peeters,et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis , 2000 .
[25] M. Okuni,et al. Clinical analysis of 570 cases with juvenile rheumatoid arthritis: Results of a nationwide retrospective survey in Japan , 1997, Acta paediatrica Japonica : Overseas edition.
[26] S. Bowyer,et al. Pediatric rheumatology clinic populations in the United States: results of a 3 year survey. Pediatric Rheumatology Database Research Group. , 1996, The Journal of rheumatology.
[27] L. Tucker,et al. Demography of a regional pediatric rheumatology patient population. Affiliated Children's Arthritis Centers of New England. , 1994, The Journal of rheumatology.
[28] Atlanta,et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. , 2008, Arthritis and rheumatism.